Prospective Case Collection Study for New Mammography Technologies
1 other identifier
interventional
7,500
1 country
15
Brief Summary
To evaluate the safety and efficacy of the proposed investigational device and assess its clinical utility in breast cancer screening and diagnosis to support continuing technology development of the investigational technology.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2021
Longer than P75 for not_applicable
15 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 10, 2021
CompletedFirst Submitted
Initial submission to the registry
December 16, 2021
CompletedFirst Posted
Study publicly available on registry
January 20, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2026
CompletedSeptember 3, 2025
August 1, 2025
4.3 years
December 16, 2021
August 26, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Clinically acceptable image quality of the Investigational Device.
Questionnaire will be used to measure outcomes
4 years
Mammograms can be safety acquired on the Investigational Device.
Will be determined using the AE assessment.
4 years
Secondary Outcomes (2)
The ease of positioning and usability of the Investigational Device.
4 years
Subject assessment of comfort of the Investigational Device.
4 years
Study Arms (1)
Investigational Mammogram Exam
EXPERIMENTALInterventions
All subjects who are indicated for a screening or diagnostic mammogram or breast biopsy will undergo an investigational exam in a new mammography device.
Eligibility Criteria
You may qualify if:
- Subject is female of any race and ethnicity.
- Subject is at least 35 years old.
- Subject is indicated for a screening or diagnostic mammogram or breast biopsy.
You may not qualify if:
- Subject is pregnant or thinks she may be pregnant
- Subject has breast implants, cardiac pacemakers, nipple piercings, or IV ports in the mammography field of view.
- Subject previously participated in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hologic, Inc.lead
Study Sites (15)
Banner MD Anderson Cancer Center
Gilbert, Arizona, 85234, United States
Southwest Medical Imaging
Gilbert, Arizona, 85297, United States
Scottsdale Medical Imaging LTD
Scottsdale, Arizona, 85251, United States
Miami Breast Institute
Coral Gables, Florida, 33146, United States
Diagnostic Centers of America Palm Beach Gardens
Palm Beach Gardens, Florida, 33410, United States
Diagnostic Centers of America West Palm Beach
West Palm Beach, Florida, 33401, United States
Baptist Health
Louisville, Kentucky, 40207, United States
Progressive Radiology
Bel Air, Maryland, 21014, United States
Corewell Health
Grand Rapids, Michigan, 49503, United States
Elizabeth Wendy Breast Care
Rochester, New York, 14620, United States
Solis Mammography Greensboro
Greensboro, North Carolina, 27401, United States
Solis Mammography Columbus
Columbus, Ohio, 43214, United States
Solis Mammography Burleson
Burleson, Texas, 76028, United States
Washington Radiology
Arlington, Virginia, 22201, United States
Washington Radiology
Sterling, Virginia, 20166, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 16, 2021
First Posted
January 20, 2022
Study Start
December 10, 2021
Primary Completion
March 31, 2026
Study Completion
March 31, 2026
Last Updated
September 3, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share
To protect participant privacy and comply with the IRB. The IRB did not approved the secondary use of IPD at the time the protocol was approved.